Back

A novel drug candidate targeting the adrenergic regulation of the SERCA2 complex protect the heart from myocardial infarct injury

21 May 2023 (10:36 - 12:12)
Organised by: Logo
Congress Presentation Part of: ePosters in basic science 3 Signal Transduction, Mechanotransduction HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Mrs Ana Calejo

Serca Pharmaceuticals, Oslo (Norway)

3 More presentations in this session

Presentation thumbnail
Single-nuclei sequencing of diabetic cardiomyopathy mouse reveals extent of immune activation and modulated by sacubitril/valsartan
Mr N. Karuna (Belfast, GB)
Abstract Slides
Presentation thumbnail
The safety of stem cells transplantation in patients with heart failure from waiting list: focus on latent viral infection
Miss A. Esmaeil (Chernivtsi, UA)
Abstract Slides
Presentation thumbnail
Can Troponin-I be an independent predictor of COVID-19 long-term cardiovascular outcomes?
Doctor J. Quintal (Setubal, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in basic science 3

The Event

Event poster

Heart Failure 2023

21 May 2023 10:36 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources